Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3??5?-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity

Johan Luthman(Karolinska Institutet), Richard F. Cowburn(AstraZeneca (Singapore)), David A. Young(Newcastle University), Elisabet Lindqvist(Lund University)
Experimental Brain Research
December 1, 1990
Cited by 58


Related Papers